Literature DB >> 11278278

Comodulation of CXCR4 and CD26 in human lymphocytes.

C Herrera1, C Morimoto, J Blanco, J Mallol, F Arenzana, C Lluis, R Franco.   

Abstract

We provide convergent and multiple evidence for a CD26/CXCR4 interaction. Thus, CD26 codistributes with CXCR4, and both coimmunoprecipitate from membranes of T (CD4(+)) and B (CD4(-)) cell lines. Upon induction with stromal cell-derived factor 1alpha (SDF-1alpha), CD26 is cointernalized with CXCR4. CXCR4-mediated down-regulation of CD26 is not induced by antagonists or human immunodeficiency virus (HIV)-1 gp120. SDF-1alpha-mediated down-regulation of CD26 is not blocked by pertussis toxin but does not occur in cells expressing mutant CXCR4 receptors unable to internalize. Codistribution and cointernalization also occurs in peripheral blood lymphocytes. Since CD26 is a cell surface endopeptidase that has the capacity to cleave SDF-1alpha, the CXCR4.CD26 complex is likely a functional unit in which CD26 may directly modulate SDF-1alpha-induced chemotaxis and antiviral capacity. CD26 anchors adenosine deaminase (ADA) to the lymphocyte cell surface, and this interaction is blocked by HIV-1 gp120. Here we demonstrate that gp120 interacts with CD26 and that gp120-mediated disruption of ADA/CD26 interaction is a consequence of a first interaction of gp120 with a domain different from the ADA binding site. SDF-1alpha and gp120 induce the appearance of pseudopodia in which CD26 and CXCR4 colocalize and in which ADA is not present. The physical association of CXCR4 and CD26, direct or part of a supramolecular structure, suggests a role on the function of the immune system and the pathophysiology of HIV infection.

Entities:  

Mesh:

Substances:

Year:  2001        PMID: 11278278     DOI: 10.1074/jbc.M004586200

Source DB:  PubMed          Journal:  J Biol Chem        ISSN: 0021-9258            Impact factor:   5.157


  30 in total

Review 1.  Cut to the chase: a review of CD26/dipeptidyl peptidase-4's (DPP4) entanglement in the immune system.

Authors:  C Klemann; L Wagner; M Stephan; S von Hörsten
Journal:  Clin Exp Immunol       Date:  2016-05-13       Impact factor: 4.330

2.  SDF-1α in glycan nanoparticles exhibits full activity and reduces pulmonary hypertension in rats.

Authors:  Tao Yin; Andrew R Bader; Tim K Hou; Bradley A Maron; Derrick D Kao; Ray Qian; Daniel S Kohane; Diane E Handy; Joseph Loscalzo; Ying-Yi Zhang
Journal:  Biomacromolecules       Date:  2013-10-18       Impact factor: 6.988

Review 3.  What doesn't kill you makes you stranger: Dipeptidyl peptidase-4 (CD26) proteolysis differentially modulates the activity of many peptide hormones and cytokines generating novel cryptic bioactive ligands.

Authors:  Ahmed M Elmansi; Mohamed E Awad; Nada H Eisa; Dmitry Kondrikov; Khaled A Hussein; Alexandra Aguilar-Pérez; Samuel Herberg; Sudharsan Periyasamy-Thandavan; Sadanand Fulzele; Mark W Hamrick; Meghan E McGee-Lawrence; Carlos M Isales; Brian F Volkman; William D Hill
Journal:  Pharmacol Ther       Date:  2019-02-10       Impact factor: 12.310

4.  Effects of linagliptin on human immortalized podocytes: a cellular system to study dipeptidyl-peptidase 4 inhibition.

Authors:  Gianluca Miglio; Giovanna Vitarelli; Thomas Klein; Elisa Benetti
Journal:  Br J Pharmacol       Date:  2017-03-06       Impact factor: 8.739

Review 5.  T-cell activation via CD26 and caveolin-1 in rheumatoid synovium.

Authors:  Kei Ohnuma; Hiroshi Inoue; Masahiko Uchiyama; Tadanori Yamochi; Osamu Hosono; Nam H Dang; Chikao Morimoto
Journal:  Mod Rheumatol       Date:  2006       Impact factor: 3.023

6.  Characterization of the migration of lung and blood T cells in response CXCL12 in a three-dimensional matrix.

Authors:  Caroline E Day; Cristina Guillen; Gary B Willars; Andrew J Wardlaw
Journal:  Immunology       Date:  2010-03-17       Impact factor: 7.397

Review 7.  DPPIV/CD26: a tumor suppressor or a marker of malignancy?

Authors:  Aline Beckenkamp; Samuel Davies; Júlia Biz Willig; Andréia Buffon
Journal:  Tumour Biol       Date:  2016-03-04

8.  Glucocorticoids mobilize macrophages by transcriptionally up-regulating the exopeptidase DPP4.

Authors:  David Diaz-Jimenez; Maria Grazia Petrillo; Jonathan T Busada; Marcela A Hermoso; John A Cidlowski
Journal:  J Biol Chem       Date:  2020-01-27       Impact factor: 5.157

9.  A potential role for dendritic cell/macrophage-expressing DPP4 in obesity-induced visceral inflammation.

Authors:  Jixin Zhong; Xiaoquan Rao; Jeffrey Deiuliis; Zachary Braunstein; Vimal Narula; Jeffrey Hazey; Dean Mikami; Bradley Needleman; Abhay R Satoskar; Sanjay Rajagopalan
Journal:  Diabetes       Date:  2012-08-30       Impact factor: 9.461

10.  CD26 expression on T cell lines increases SDF-1-alpha-mediated invasion.

Authors:  P A Havre; M Abe; Y Urasaki; K Ohnuma; C Morimoto; N H Dang
Journal:  Br J Cancer       Date:  2009-08-04       Impact factor: 7.640

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.